Cargando…

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria

BACKGROUND: Cold contact urticaria (CCU) is characterized by itchy wheal and flare responses due to the release of histamine and other pro-inflammatory mediators after exposure to cold. The treatment of choice is nonsedating antihistamines, dosages of which may be increased up to fourfold if standar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krause, K, Spohr, A, Zuberbier, T, Church, M K, Maurer, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759706/ https://www.ncbi.nlm.nih.gov/pubmed/23742030 http://dx.doi.org/10.1111/all.12171

Ejemplares similares

The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016)

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
por: Shah, Bela, et al.
Publicado: (2022)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)

H(1)-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study
por: Weller, Karsten, et al.
Publicado: (2011)

Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey
por: Du-Thanh, Aurélie, et al.
Publicado: (2022)

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017)

Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients
por: De, Abhishek, et al.
Publicado: (2021)

Classification of Urticaria
por: Zuberbier, Torsten
Publicado: (2013)

One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
por: Yagami, Akiko, et al.
Publicado: (2016)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Treatment of Severe Cold Contact Urticaria with Omalizumab: Case Reports
por: Brodská, Petra, et al.
Publicado: (2012)

Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency
por: Lasseter, Kenneth C., et al.
Publicado: (2013)

Cold Agglutinins and Cryoglobulins Associate With Clinical and Laboratory Parameters of Cold Urticaria
por: Bizjak, Mojca, et al.
Publicado: (2021)

Application of a dual mechanistic approach to support bilastine dose selection for older adults
por: Kim, Chaejin, et al.
Publicado: (2021)

Cryoglobulins, Cryofibrinogens, and Cold Agglutinins in Cold Urticaria: Literature Review, Retrospective Patient Analysis, and Observational Study in 49 Patients
por: Ginter, Katharina, et al.
Publicado: (2021)

Clinical review: The suggested management pathway for urticaria in primary care
por: Ryan, Dermot, et al.
Publicado: (2022)

PD38 - Clinical features and natural history of cold contact urticaria in children
por: Pananaki, Anna, et al.
Publicado: (2014)

Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice
por: Verta, Roberta, et al.
Publicado: (2019)

Urticaria in Pregnancy and Lactation
por: Kocatürk, Emek, et al.
Publicado: (2022)

Effects of a Novel GA(2)LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-Arabia
por: Maurer, Marcus, et al.
Publicado: (2011)

On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria
por: Lakin, Elisa, et al.
Publicado: (2019)

Contact Urticaria to Glycolic Acid Peel
por: Vishal, B, et al.
Publicado: (2012)

CONTACT URTICARIA: PRESENT SCENARIO
por: Bhatia, Ruchi, et al.
Publicado: (2009)

Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
por: Popov, Todor A., et al.
Publicado: (2019)

Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab
por: Stroet, Leonie C., et al.
Publicado: (2021)

Mast Cell Dependent Vascular Changes Associated with an Acute Response to Cold Immersion in Primary Contact Urticaria
por: Meyer, Joseph, et al.
Publicado: (2013)

Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
por: Fukunaga, Atsushi, et al.
Publicado: (2020)

Effectiveness of bilastine and fexofenadine among allergic Rhinitis patients in Ranchi, Jharkhand, India
por: Kumari, Abha, et al.
Publicado: (2022)

Green quality by design HPLC approach for the simultaneous determination of Bilastine and Montelukast
por: Roshdy, Aya, et al.
Publicado: (2023)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
por: Casale, Thomas B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9se261j46hbidvh843mouum4n0